Old Web
English
Sign In
Acemap
>
Paper
>
FRI-433-Bevacizumab for the treatment of liver involvement in patients with hereditary hemorrhagic telangiectasia
FRI-433-Bevacizumab for the treatment of liver involvement in patients with hereditary hemorrhagic telangiectasia
2019
Assaf Issachar
Michal Cohen-Naftaly
Orly Sneh Arbib
Ran Tur-Kaspa
Amir Shlomai
Marius Braun
Meir Mei-Zahav
Keywords:
Bevacizumab
Telangiectasia
Virology
Gastroenterology
Diabetes mellitus
Internal medicine
Medicine
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]